vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v22i5.2638vsp-3297Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWВопросы терапии и профилактики инфекционных осложнений атопического дерматита у детейManagement and Prevention of Atopic Dermatitis Infectious Complications in Childrenhttps://orcid.org/0000-0002-4107-4642ЕпишевР. В.EpishevRoman V.

Епишев Роман Владимирович - кандидат медицинских наук, врач-дерматовенеролог отделения дерматологии и аллергологии НИИ детской дерматологии ФГАУ «НМИЦ здоровья детей» Минздрава России

119991, Москва, Ломоносовский пр-т, д. 2, стр. 1,  тел.: +7 (499) 134-09-15

Moscow

drepishev@gmail.comhttps://orcid.org/0000-0002-6034-8231МатерикинА. И.MaterikinAlexander I.

Москва

Moscow

https://orcid.org/0000-0002-0858-8780ОпрятинЛ. А.OpryatinLeonid A.

Москва

Moscow

https://orcid.org/0000-0002-0081-0981ИвановР. А.IvanovRoman A.

Москва

Moscow

https://orcid.org/0000-0001-5739-0941ЛеоноваМ. А.LeonovaMaria A.

Москва

Moscow

https://orcid.org/0000-0001-6884-5171СавеловаА. А.SavelovaAlena A.

Москва

Moscow

НМИЦ здоровья детейРоссияNational Medical Research Center of Children’s HealthRussian Federation202305112023225374381Copyright © Епишев Р.В., Материкин А.И., Опрятин Л.А., Иванов Р.А., Леонова М.А., Савелова А.А., 20232023Епишев Р.В., Материкин А.И., Опрятин Л.А., Иванов Р.А., Леонова М.А., Савелова А.А.Epishev R.V., Materikin A.I., Opryatin L.A., Ivanov R.A., Leonova M.A., Savelova A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/3297

Атопический дерматит (АтД) — хроническое воспалительное заболевание кожи, осложняющееся повышенным риском кожных и системных инфекций. Профилактическая терапия АтД основана на улучшении кожного барьера и противовоспалительных методах лечения, в то время как тяжелые кожные и системные инфекции требуют назначения системной терапии. В данном обзоре представлены патофизиология и возможные методы лечения и профилактики инфекционных осложнений АтД.

Atopic dermatitis (AD) is a chronic inflammatory skin disease with high risk of skin and systemic infections. Preventive AD therapy is based on skin barrier improvement and anti-inflammatory treatment, whereas, severe skin and systemic infections require systemic therapy. This review describes pathophysiology and possible treatment and prevention methods for AD infectious complications.

атопический дерматитвторичное инфицированиемикробиомStaphylococcus aureusдетиatopic dermatitissecondary infectionmicrobiomeStaphylococcus aureuschildrenСтатья опубликована при финансовой поддержке ООО «Пьер Фабр»The article was published with the financial support of Pierre Fabre LLCReferencesLangan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360. doi: https://doi.org/10.1016/S01406736(20)31286-1Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360. doi: https://doi.org/10.1016/S01406736(20)31286-1Емельяшенков Е.Е., Свиридова Т.В., Мурашкин Н.Н. и др. Психологическая готовность родителей детей раннего возраста с атопическим дерматитом к выполнению рекомендаций врачей // Российский педиатрический журнал. — 2023. — Т. 26. — № 1. — С. 46–53. — doi: https://doi.org/10.46563/1560-95612023-26-1-46-53Emelyashenkov EE, Sviridova TV, Murashkin NN, et al. Psychological readiness of parents of young children with atopic dermatitis to implement medical recommendations. Russian Pediatric Journal. 2023;26(1):46–53. (In Russ). doi: https://doi.org/10.46563/1560-9561-2023-26-1-46-53Ali F, Vyas J, Finlay AY. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Derm Venereol. 2020;100(12): adv00161. doi: https://doi.org/10.2340/00015555-3511Ali F, Vyas J, Finlay AY. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Derm Venereol. 2020;100(12): adv00161. doi: https://doi.org/10.2340/00015555-3511Edslev SM, Agner T, Andersen PS. Skin Microbiome in Atopic Dermatitis. Acta Derm Venereol. 2020;100(12):adv00164. doi: https://doi.org/10.2340/00015555-3514Edslev SM, Agner T, Andersen PS. Skin Microbiome in Atopic Dermatitis. Acta Derm Venereol. 2020;100(12):adv00164. doi: https://doi.org/10.2340/00015555-3514Narla S, Silverberg JI. Association between atopic dermatitis and serious cutaneous, multiorgan, and systemic infections in US adults. Ann Allergy Asthma Immunol. 2018;120(1):66–72.e11. doi: https://doi.org/10.1016/j.anai.2017.10.019Narla S, Silverberg JI. Association between atopic dermatitis and serious cutaneous, multiorgan, and systemic infections in US adults. Ann Allergy Asthma Immunol. 2018;120(1):66–72.e11. https://doi.org/10.1016/j.anai.2017.10.019Wang V, Keefer M, Ong PY. Antibiotic choice and methicillinresistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):314–317. doi: https://doi.org/10.1016/j.anai.2018.12.001Wang V, Keefer M, Ong PY. Antibiotic choice and methicillinresistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):314–317. doi: https://doi.org/10.1016/j.anai.2018.12.001Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8–16. doi: https://doi.org/10.1159/000370220Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8–16. doi: https://doi.org/10.1159/000370220Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1. doi: https://doi.org/10.1038/s41572-018-0001-zWeidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1. doi: https://doi.org/10.1038/s41572-018-0001-zTsakok T, Woolf R, Smith CH, et al. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2019;180(3):464–474. doi: https://doi.org/10.1111/bjd.16934Tsakok T, Woolf R, Smith CH, et al. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2019;180(3):464–474. doi: https://doi.org/10.1111/bjd.16934Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. doi: https://doi.org/10.1186/s13223-018-0281-6Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. doi: https://doi.org/10.1186/s13223-018-0281-6Elias PM, Sugarman J. Does moisturizing the skin equate with barrier repair therapy? Ann Allergy Asthma Immunol. 2018;121(6) 653–656.e2. doi: https://doi.org/10.1016/j.anai.2018.07.008Elias PM, Sugarman J. Does moisturizing the skin equate with barrier repair therapy? Ann Allergy Asthma Immunol. 2018;121(6) 653–656.e2. doi: https://doi.org/10.1016/j.anai.2018.07.008Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5):657–682. doi: https://doi.org/10.1111/jdv.14891Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5):657–682. doi: https://doi.org/10.1111/jdv.14891Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3): 329–337. doi: https://doi.org/10.1007/s12016-016-8548-5Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3): 329–337. doi: https://doi.org/10.1007/s12016-016-8548-5Paller AS, Kong HH, Seed P, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143(1):26–35. doi: https://doi.org/10.1016/j.jaci.2018.11.015Paller AS, Kong HH, Seed P, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143(1):26–35. doi: https://doi.org/10.1016/j.jaci.2018.11.015Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol. 2004;5(4):217–223. doi: https://doi.org/10.2165/00128071-200405040-00002Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol. 2004;5(4):217–223. doi: https://doi.org/10.2165/00128071-200405040-00002Smieszek SP, Welsh S, Xiao C, et al. Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status. Sci Rep. 2020;10(1):2721. doi: https://doi.org/1010.1038/s41598-020-59627-7Smieszek SP, Welsh S, Xiao C, et al. Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status. Sci Rep. 2020;10(1):2721. doi: https://doi.org/1010.1038/s41598-020-59627-7Berdyshev E, Goleva E, Bronova I, et al. Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. 2018;3(4):e98006. doi: https://doi.org/10.1172/jci.insight.98006Berdyshev E, Goleva E, Bronova I, et al. Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. 2018;3(4):e98006. doi: https://doi.org/10.1172/jci.insight.98006Malik K, Heitmiller KD, Czarnowicki T. An update on the pathophysiology of atopic dermatitis. Dermatol Clin. 2017;35(3): 317–326. doi: https://doi.org/10.1016/j.det.2017.02.006Malik K, Heitmiller KD, Czarnowicki T. An update on the pathophysiology of atopic dermatitis. Dermatol Clin. 2017;35(3): 317–326. doi: https://doi.org/10.1016/j.det.2017.02.006Stier MT, Peebles RS Jr. Innate lymphoid cells and allergic disease. Ann Allergy Asthma Immunol. 2017;119(6):480–488. doi: https://doi.org/10.1016/j.anai.2017.08.290Stier MT, Peebles RS Jr. Innate lymphoid cells and allergic disease. Ann Allergy Asthma Immunol. 2017;119(6):480–488. doi: https://doi.org/10.1016/j.anai.2017.08.290Мурашкин Н.Н., Епишев Р.В., Фёдоров Д.В. и др. Синдром чувствительной кожи при атопическом дерматите у детей: особенности патогенеза и терапевтической тактики // Вопросы современной педиатрии. — 2019. — Т. 18. — № 4. — С. 285–293. — doi: https://doi.org/10.15690/vsp.v18i4.2046Murashkin NN, Epishev RV, Fedorov DV, et al. Sensitive Skin Syndrome in Children with Atopic Dermatitis: Pathogenesis and Management Features. Voprosy sovremennoi pediatrii — Current Pediatrics. 2019;18(4):285–293. (In Russ). doi: https://doi.org/10.15690/vsp.v18i4.2046Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347(15):1151–1160. doi: https://doi.org/10.1056/NEJMoa021481Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347(15):1151–1160. doi: https://doi.org/10.1056/NEJMoa021481Ryffel B, Alves-Filho JC. ILC2s and basophils team up to orchestrate IL-33-induced atopic dermatitis. J Invest Dermatol. 2019;139(10): 2077–2079. doi: https://doi.org/10.1016/j.jid.2019.06.118Ryffel B, Alves-Filho JC. ILC2s and basophils team up to orchestrate IL-33-induced atopic dermatitis. J Invest Dermatol. 2019;139(10): 2077–2079. doi: https://doi.org/10.1016/j.jid.2019.06.118Leyva-Castillo JM, Galand C, Mashiko S, et al. ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation. J Allergy Clin Immunol. 2020;145(6):1606–1614.e4. doi: https://doi.org/10.1016/j.jaci.2020.02.026Leyva-Castillo JM, Galand C, Mashiko S, et al. ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation. J Allergy Clin Immunol. 2020;145(6):1606–1614.e4. doi: https://doi.org/10.1016/j.jaci.2020.02.026Iwamoto K, Nümm TJ, Koch S, et al. Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized toward TLR2 activation. Allergy. 2018;73(11):2205–2213. doi: https://doi.org/10.1111/all.13460Iwamoto K, Nümm TJ, Koch S, et al. Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized toward TLR2 activation. Allergy. 2018;73(11):2205–2213. doi: https://doi.org/10.1111/all.13460Mack MR, Brestoff JR, Berrien-Elliott MM, et al. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. 2020;12(532):eaay1005. doi: https://doi.org/10.1126/scitranslmed.aay1005Mack MR, Brestoff JR, Berrien-Elliott MM, et al. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. 2020;12(532):eaay1005. doi: https://doi.org/10.1126/scitranslmed.aay1005Мурашкин Н.Н., Савелова А.А., Иванов Р.А. и др. Современные представления о роли эпидермального барьера в развитии атопического фенотипа у детей // Вопросы современной педиатрии. — 2019. — Т. 18. — № 5. — С. 386–392. —Murashkin NN, Savelova AA, Ivanov RA, et al. Modern View on the Role of Epidermal Barrier in Atopic Phenotype Development in Children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2019;18(5):386–392. (In Russ). doi: https://doi.org/10.15690/vsp.v18i5.2064Baker BS, Ovigne JM, Powles AV, et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol. 2003;148(4):670–679. doi: https://doi.org/10.1046/j.1365-2133.2003.05287.xBaker BS, Ovigne JM, Powles AV, et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol. 2003;148(4):670–679. doi: https://doi.org/10.1046/j.1365-2133.2003.05287.xPivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003;15(6):721–730. doi: https://doi.org/10.1093/intimm/dxg068Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003;15(6):721–730. doi: https://doi.org/10.1093/intimm/dxg068Mempel M, Voelcker V, Kollisch G, et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not tolllike receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003;121(6):1389–1396. doi: https://doi.org/10.1111/j.1523-1747.2003.12630.xMempel M, Voelcker V, Kollisch G, et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not tolllike receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003;121(6):1389–1396. doi: https://doi.org/10.1111/j.1523-1747.2003.12630.xChen K, Huang J, Gong W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007;7(10):1271–1285. doi: https://doi.org/10.1016/j.intimp.2007.05.016Chen K, Huang J, Gong W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007;7(10):1271–1285. doi: https://doi.org/10.1016/j.intimp.2007.05.016Gao N, Kumar A, Jyot J, Yu FS. Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. PLoS One. 2010;5(2): e9351. doi: https://doi.org/10.1371/journal.pone.0009351Gao N, Kumar A, Jyot J, Yu FS. Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaBindependent and EGFR-dependent pathway. PLoS One. 2010;5(2): e9351. doi: https://doi.org/10.1371/journal.pone.0009351Leifer CA, McConkey C, Li S, et al. Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome’s potential to cause inflammation. Immunol Lett. 2014;162(2 Pt A):3–9. doi: https://doi.org/10.1016/j.imlet.2014.07.017Leifer CA, McConkey C, Li S, et al. Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome’s potential to cause inflammation. Immunol Lett. 2014;162(2 Pt A):3–9. doi: https://doi.org/10.1016/j.imlet.2014.07.017Kondo Y, Higa-Nakamine S, Noguchi N, et al. Induction of epithelialmesenchymal transition by flagellin in cultured lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2012;303(12):L1057–L1069. doi: https://doi.org/10.1152/ajplung.00096.2012Kondo Y, Higa-Nakamine S, Noguchi N, et al. Induction of epithelialmesenchymal transition by flagellin in cultured lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2012;303(12):L1057–L1069. doi: https://doi.org/10.1152/ajplung.00096.2012Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int. 2022;71(1):31–39. doi: https://doi.org/10.1016/j.alit.2021.11.001Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int. 2022;71(1):31–39. doi: https://doi.org/10.1016/j.alit.2021.11.001Fyhrquist N, Muirhead G, Prast-Nielsen S, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10(1): 4703. doi: https://doi.org/10.1038/s41467-019-12253-yFyhrquist N, Muirhead G, Prast-Nielsen S, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10(1): 4703. doi: https://doi.org/10.1038/s41467-019-12253-yKim J, Kim BE, Ahn K, Leung DYM. Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications. Allergy Asthma Immunol Res. 2019;11(5):593–603. doi: https://doi.org/10.4168/aair.2019.11.5.593Kim J, Kim BE, Ahn K, Leung DYM. Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications. Allergy Asthma Immunol Res. 2019;11(5):593–603. doi: https://doi.org/10.4168/aair.2019.11.5.593Orfali RL, Yoshikawa FSY, Oliveira LMDS, et al. Staphylococcal enterotoxins modulate the effector CD4+ T cell response by reshaping the gene expression profile in adults with atopic dermatitis. Sci Rep. 2019;9(1):13082. doi: https://doi.org/10.1038/s41598-019-49421-5Orfali RL, Yoshikawa FSY, Oliveira LMDS, et al. Staphylococcal enterotoxins modulate the effector CD4+ T cell response by reshaping the gene expression profile in adults with atopic dermatitis. Sci Rep. 2019;9(1):13082. doi: https://doi.org/10.1038/s41598-019-49421-5Orfali RL, da Silva Oliveira LM, de Lima JF, et al. Staphylococcus aureus enterotoxins modulate IL-22-secreting cells in adults with atopic dermatitis. Sci Rep. 2018;8(1):6665. doi: https://doi.org/10.1038/s41598-018-25125-0Orfali RL, da Silva Oliveira LM, de Lima JF, et al. Staphylococcus aureus enterotoxins modulate IL-22-secreting cells in adults with atopic dermatitis. Sci Rep. 2018;8(1):6665. doi: https://doi.org/10.1038/s41598-018-25125-0Leistner R, Hanitsch LG, Krüger R, et al. Skin Infections Due to Panton-Valentine Leukocidin-Producing S. Aureus. Dtsch Arztebl Int. 2022;119(45):775–784. doi: https://doi.org/10.3238/arztebl.m2022.0308Leistner R, Hanitsch LG, Krüger R, et al. Skin Infections Due to Panton-Valentine Leukocidin-Producing S. Aureus. Dtsch Arztebl Int. 2022;119(45):775–784. doi: https://doi.org/10.3238/arztebl.m2022.0308Мурашкин Н.Н., Епишев Р.В., Материкин А.И. и др. Механизмы формирования и возможности терапевтической коррекции стероидрезистентности у пациентов с атопическим дерматитом // Вопросы современной педиатрии. — 2021. — Т. 20. — № 5. — С. 370–375. — doi: https://doi.org/10.15690/vsp.v20i5.2309Murashkin NN, Epishev RV, Materikin AI, et al. Mechanisms of Development and Variants of Therapeutic Management of Steroid Resistance in Patients with Atopic Dermatitis. Voprosy sovremennoi pediatrii — Current Pediatrics. 2021;20(5):370–375. (In Russ). doi: https://doi.org/10.15690/vsp.v20i5.2309Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):263–269. doi: https://doi.org/10.1016/j.anai.2018.12.003Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):263–269. doi: https://doi.org/10.1016/j.anai.2018.12.003Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49(1): 65–71. doi: https://doi.org/10.1086/599348Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49(1): 65–71. doi: https://doi.org/10.1086/599348Francis NA, Ridd MJ, Thomas-Jones E, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15(2):124–130. doi: https://doi.org/10.1370/afm.2038Francis NA, Ridd MJ, Thomas-Jones E, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15(2):124–130. doi: https://doi.org/10.1370/afm.2038George SM, Karanovic S, Harrison DA, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019(10):CD003871. doi: https://doi.org/10.1002/14651858.CD003871.pub3George SM, Karanovic S, Harrison DA, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019(10):CD003871. doi: https://doi.org/10.1002/14651858.CD003871.pub3Harkins CP, Holden MTG, Irvine AD. Antimicrobial resistance in atopic dermatitis: need for an urgent rethink. Ann Allergy Asthma Immunol. 2019;122(3):236–240. doi: https://doi.org/10.1016/j.anai.2018.11.027Harkins CP, Holden MTG, Irvine AD. Antimicrobial resistance in atopic dermatitis: need for an urgent rethink. Ann Allergy Asthma Immunol. 2019;122(3):236–240. doi: https://doi.org/10.1016/j.anai.2018.11.027Alexander H, Paller AS, Traidl-Hoffmann C, et al. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol. 2020;182(6):1331–1342. doi: https://doi.org/10.1111/bjd.18643Alexander H, Paller AS, Traidl-Hoffmann C, et al. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol. 2020;182(6):1331–1342. doi: https://doi.org/10.1111/bjd.18643Red Book: 2018 Report of the Committee of Infectious Diseases. Kimberlin D, Brady M, Jackson M, Long S, eds. Itasca, IL: American Academy of Pediatrics; 2018.Red Book: 2018 Report of the Committee of Infectious Diseases. Kimberlin D, Brady M, Jackson M, Long S, eds. Itasca, IL: American Academy of Pediatrics; 2018.Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292. doi: https://doi.org/10.1093/cid/cir034Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292. doi: https://doi.org/10.1093/cid/cir034Guo Y, Song G, Sun M, et al. Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10:107. doi: https://doi.org/10.3389/fcimb.2020.00107Guo Y, Song G, Sun M, et al. Prevalence and Therapies of AntibioticResistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10:107. doi: https://doi.org/10.3389/fcimb.2020.00107Rose W, Fantl M, Geriak M, et al. Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? Clin Infect Dis. 2021;73(12):2353–2360. doi: https://doi.org/10.1093/cid/ciab452Rose W, Fantl M, Geriak M, et al. Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? Clin Infect Dis. 2021;73(12):2353–2360. doi: https://doi.org/10.1093/cid/ciab452Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016; 137(4):e20153099. doi: https://doi.org/10.1542/peds.2015-3099Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016; 137(4):e20153099. doi: https://doi.org/10.1542/peds.2015-3099Rangel SM, Paller AS. Bacterial colonization, overgrowth, and superinfection in atopic dermatitis. Clin Dermatol. 2018;36(5): 641–647. doi: https://doi.org/10.1016/j.clindermatol.2018.05.005Rangel SM, Paller AS. Bacterial colonization, overgrowth, and superinfection in atopic dermatitis. Clin Dermatol. 2018;36(5): 641–647. doi: https://doi.org/10.1016/j.clindermatol.2018.05.005Ashbaugh AG, Kwatra SG. Atopic Dermatitis Disease Complications. Adv Exp Med Biol. 2017;1027:47–55. doi: https://doi.org/10.1007/978-3-319-64804-0_5Ashbaugh AG, Kwatra SG. Atopic Dermatitis Disease Complications. Adv Exp Med Biol. 2017;1027:47–55. doi: https://doi.org/10.1007/978-3-319-64804-0_5Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35(1):161–183. doi: https://doi.org/10.1016/j.iac.2014.09.008Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35(1):161–183. doi: https://doi.org/10.1016/j.iac.2014.09.008Boguniewicz M, Fonacier L, Guttman-Yassky E, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1): 10–22.e2. doi: https://doi.org/10.1016/j.anai.2017.10.039Boguniewicz M, Fonacier L, Guttman-Yassky E, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1): 10–22.e2. doi: https://doi.org/10.1016/j.anai.2017.10.039Woods MT, Brown PA, Baig-Lewis SF, Simpson EL. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis. J Drugs Dermatol. 2011;10(2):171–176.Woods MT, Brown PA, Baig-Lewis SF, Simpson EL. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis. J Drugs Dermatol. 2011;10(2):171–176.Dähnhardt-Pfeiffer S, Dähnhardt D, Buchner M, et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. J Dtsch Dermatol Ges. 2013;11(5):437–443. doi: https://doi.org/10.1111/ddg.12074Dähnhardt-Pfeiffer S, Dähnhardt D, Buchner M, et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. J Dtsch Dermatol Ges. 2013;11(5):437–443. doi: https://doi.org/10.1111/ddg.12074Jensen JM, Weppner M, Dähnhardt-Pfeiffer S, et al. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. Acta Derm Venereol. 2013;93(5):515–519. doi: https://doi.org/10.2340/00015555-1533Jensen JM, Weppner M, Dähnhardt-Pfeiffer S, et al. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. Acta Derm Venereol. 2013;93(5):515–519. doi: https://doi.org/10.2340/00015555-1533Hung SH, Lin YT, Chu CY, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98(1):51–56. doi: https://doi.org/10.1016/S1081-1206(10)60859-9Hung SH, Lin YT, Chu CY, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98(1):51–56. doi: https://doi.org/10.1016/S1081-1206(10)60859-9Gong JQ, Lin L, Lin T, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680–687. doi: https://doi.org/10.1111/j.1365-2133.2006.07410.xGong JQ, Lin L, Lin T, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680–687. doi: https://doi.org/10.1111/j.1365-2133.2006.07410.xGonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75(3): 481–493.e853. doi: https://doi.org/10.1016/j.jaad.2016.04.066Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75(3): 481–493.e853. doi: https://doi.org/10.1016/j.jaad.2016.04.066Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol. 2005;175(12):8051–8059. doi: https://doi.org/10.4049/jimmunol.175.12.8051Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol. 2005;175(12):8051–8059. doi: https://doi.org/10.4049/jimmunol.175.12.8051Aries MF, Hernandez-Pigeon H, Vaissière C, et al. Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol. 2016;9:421–434. doi: https://doi.org/10.2147/CCID.S113180Aries MF, Hernandez-Pigeon H, Vaissière C, et al. Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol. 2016;9:421–434. doi: https://doi.org/10.2147/CCID.S113180Noizet M, Bianchi P, Galliano MF, et al. Broad spectrum repairing properties of an extract of Aquaphilus dolomiae on in vitro and ex vivo models of injured skin. J Eur Acad Dermatol Venereol. 2020;34 Suppl 5: 37–42. doi: https://doi.org/10.1111/jdv.16477Noizet M, Bianchi P, Galliano MF, et al. Broad spectrum repairing properties of an extract of Aquaphilus dolomiae on in vitro and ex vivo models of injured skin. J Eur Acad Dermatol Venereol. 2020;34 Suppl 5: 37–42. doi: https://doi.org/10.1111/jdv.16477Martin H, Laborel-Préneron E, Fraysse F, et al. Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4+ T cell activation. Pharm Biol. 2016;54(11):2782–2785. doi: https://doi.org/10.3109/13880209.2016.1173069Martin H, Laborel-Préneron E, Fraysse F, et al. Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4+ T cell activation. Pharm Biol. 2016;54(11):2782–2785. doi: https://doi.org/10.3109/13880209.2016.1173069Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J. 2010;51(6):808–822. doi: https://doi.org/10.3349/ymj.2010.51.6.808Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J. 2010;51(6):808–822. doi: https://doi.org/10.3349/ymj.2010.51.6.808Nguyen T, Castex-Rizzi N, Redoules D. Immunomodulatory, antiinflammatory, anti-pruritus and tolerogenic activities induced by I-modulia, an Aquaphilus dolomiae culture extract, in atopic dermatitis pharmacology models. Ann Dermatol Venereol. 2017;144(Suppl 1): S42–S49. doi: https://doi.org/10.1016/S0151-9638(17)31042-6Nguyen T, Castex-Rizzi N, Redoules D. Immunomodulatory, antiinflammatory, anti-pruritus and tolerogenic activities induced by I-modulia, an Aquaphilus dolomiae culture extract, in atopic dermatitis pharmacology models. Ann Dermatol Venereol. 2017;144(Suppl 1): S42–S49. doi: https://doi.org/10.1016/S0151-9638(17)31042-6Fostini AC, Georgescu V, Decoster CJ, Girolomoni G. A cream based on Aquaphilus dolomiae extracts alleviates non-histaminergic pruritus in humans. Eur J Dermatol. 2017;27(3):317–318. doi: https://doi.org/10.1684/ejd.2017.2994Fostini AC, Georgescu V, Decoster CJ, Girolomoni G. A cream based on Aquaphilus dolomiae extracts alleviates non-histaminergic pruritus in humans. Eur J Dermatol. 2017;27(3):317–318. doi: https://doi.org/10.1684/ejd.2017.2994Guerrero D, Mengeaud V, Verriere F, Nocera T. Efficacy and tolerabity of an association with cooper, zinc and sucralfate in dermatology. Les Nouvelles Dermatol. 2002;21(Suppl.2):20–23.Guerrero D, Mengeaud V, Verriere F, Nocera T. Efficacy and tolerabity of an association with cooper, zinc and sucralfate in dermatology. Les Nouvelles Dermatol. 2002;21(Suppl.2):20–23.Schwartz JR, Marsh RG, Draelos ZD. Zinc and skin health: overview of physiology and pharmacology. Dermatol Surg. 2005;31 (7 Pt 2):837–847; discussion 847. doi: https://doi.org/10.1111/j.1524-4725.2005.31729Schwartz JR, Marsh RG, Draelos ZD. Zinc and skin health: overview of physiology and pharmacology. Dermatol Surg. 2005;31 (7 Pt 2):837–847; discussion 847. doi: https://doi.org/10.1111/j.1524-4725.2005.31729Baldwin S, Odio MR, Haines SL, et al. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper. J Eur Acad Dermatol Venereol. 2001; 15 Suppl 1:5–11. doi: https://doi.org/10.1046/j.0926-9959.2001.00002.xBaldwin S, Odio MR, Haines SL, et al. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper. J Eur Acad Dermatol Venereol. 2001; 15 Suppl 1:5–11. doi: https://doi.org/10.1046/j.0926-9959. 2001.00002.xMerial-Kieny C, Castex-Rizzi N, Selas B, et al. Avène Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol. 2011;25 Suppl 1:2–5. doi: https://doi.org/10.1111/j.1468-3083.2010.03892.xMerial-Kieny C, Castex-Rizzi N, Selas B, et al. Avène Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol. 2011;25 Suppl 1:2–5. doi: https://doi.org/10.1111/j.1468-3083.2010.03892.xJoly F, Charveron M, Ariès MF, et al. Effect of Avène spring water on the activation of rat mast cell by substance P or antigen. Skin Pharmacol Appl Skin Physiol. 1998;11(2):111–116. doi: https://doi.org/10.1159/000029816Joly F, Charveron M, Ariès MF, et al. Effect of Avène spring water on the activation of rat mast cell by substance P or antigen. Skin Pharmacol Appl Skin Physiol. 1998;11(2):111–116. doi: https://doi.org/10.1159/000029816Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avène spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int J Tissue React. 2001;23(3):89–95.Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avène spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int J Tissue React. 2001;23(3):89–95.Casas C, Ginisty H, Alvarez-Georges S, et al. Molecular characterization of inflammation and Staphylococcus aureus colonization of involved skin of atopic dermatitis patients A non-invasive approach. Skin Pharmacol Physiol. 2008;21(5):260–268. doi: https://doi.org/10.1159/000143391Casas C, Ginisty H, Alvarez-Georges S, et al. Molecular characterization of inflammation and Staphylococcus aureus colonization of involved skin of atopic dermatitis patients A non-invasive approach. Skin Pharmacol Physiol. 2008;21(5):260–268. doi: https://doi.org/10.1159/000143391

The authors declare that there are no conflicts of interest present.